This week we have a two-hour-long, far-ranging interview with Dr. John Ioannidis of Stanford University on, broadly, meta-research and COVID-19 – including his recent controversies. We end the episode
The phase 3 PROfound trial led to the recent approval of the PARP inhibitor olaparib for men with metastatic castration-resistant prostate cancer and mutations in…
Cancer is deadly, but 68% of the drugs approved by FDA have no evidence they increase survival!
It does the least harm to kids and adults
This review of approvals of cancer drugs based on a surrogate end point by the US Food and Drug Administration assesses the postmarketing findings for…
Cancer Medicine is an open access, broad-scope oncology journal covering clinical cancer research, cancer biology, cancer prevention, & bioinformatics.
Students in their first year of medical school typically learn what a healthy body looks like and how to keep it that way. At the…
Can journalism aspire to be curious?
Can journalism aspire to be curious?
